Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBbva Ord Regulatory News (BVA)

Share Price Information for Bbva Ord (BVA)

Share Price is delayed by 15 minutes
Get Live Data
21.00    0.00 (0.00%)
Bid:
21.20
Ask:
22.20
Spread: 1.00 (4.717%)
Market Cap: €116.56b
BVA Live PriceLast checked at - London Stock Exchange

Intraday Bbva Ord Share Chart

BBVA offer modification

9 Jan 2025 17:48

RNS Number : 8202S
Banco Bilbao Vizcaya Argentaria SA
09 January 2025
 

Banco Bilbao Vizcaya Argentaria, S.A. ("BBVA"), in accordance with the provisions of the Securities Market legislation, hereby communicates, at the request of the Spanish Securities Market Commission (CNMV) and in accordance with the provisions of Article 234 of Law 6/2023, of March 17, on Securities Markets and Investment Services, the following:

 

INSIDE INFORMATION

 

In relation to the voluntary tender offer launched by BBVA for the entire share capital of Banco de Sabadell, S.A. ("Banco Sabadell" or the "Target Company") (the "Offer"), for which the prior announcement was published as inside information on May 9, 2024 and the request for authorisation was submitted to the CNMV on May 24, 2024 and gave leave to proceed on June 11, 2024, BBVA informs that it has decided to modify the Offer by reducing the minimum acceptance condition provided in the prior announcement, which implies a more favorable treatment for its recipients, in accordance with Article 31.1 of Royal Decree 1066/2007.

The aforementioned minimum acceptance condition, which initially required the acceptance of the Offer by at least 2,720,654,746 shares of the Target Company, representing 50.01 percent of its share capital, is now reduced so that it requires the Offer to be accepted for a number of shares that allows BBVA to acquire at least more than half of the effective voting rights of Banco Sabadell at the end of the Offer acceptance period (therefore excluding the treasury shares that the Target Company may hold at that time).

As of the date of this communication, the total share capital with voting rights amounts to 5,361,450,912 ordinary shares (5,361,450 effective voting rights), considering that Banco Sabadell's share capital is represented by a total of 5,440,221,447 ordinary shares (5,440,221 voting rights) and that it holds 78,770,535 treasury shares (as stated in Banco Sabadell's Universal Registration Document posted on the CNMV's website on May 23, 2024), whose voting rights are suspended in accordance with Article 148(a) of the Spanish Companies Act. Therefore, assuming that all such treasury shares remain as such at the end of the Offer acceptance period, the reduced minimum acceptance condition will be deemed fulfilled if the Offer is accepted for at least 2,680,726,000 shares of Banco Sabadell (2,680,726 voting rights), which would represent half plus one of Banco Sabadell's effective voting rights at that time.

The above notwithstanding, if Banco Sabadell's treasury shares vary by the end of the acceptance period, the condition will be deemed fulfilled if the Offer is accepted for the number of shares necessary to acquire more than 50 percent of the effective voting rights at that time, thus excluding the suspended voting rights corresponding to the treasury shares held by Banco Sabadell on that date.

In the event of a positive outcome of the Offer, BBVA will seek the redemption of Banco Sabadell's treasury shares at the end of the acceptance period at the first General Shareholders' Meeting of Banco Sabadell, reducing the share capital and locking up those shares in the meantime. 

The fulfillment of this reduced minimum acceptance condition, under the described terms, will make applicable the exception to the obligation to launch a mandatory tender offer in accordance with Article 8(f) of Royal Decree 1066/2007, to the extent that the Offer would have been accepted for shares representing, at least, 50 percent of the effective voting rights to which it was addressed.

BBVA will submit to the CNMV the documentation related to the improved terms of the Offer in accordance with Articles 17 and 20 of Royal Decree 1066/2007.

 

 

Madrid, January 9, 2025

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCSSIFWUEISELF
Date   Source Headline
24th Oct 20165:02 pmRNSHR 3Q16 Results presentation announcement
20th Oct 20167:00 amRNSEnding trading period Divend Option October 2016
29th Sep 20167:00 amRNSDividend Option Information October 2016
16th Sep 20161:43 pmRNSDividend Option Calendar October 2016
9th Sep 20165:26 pmRNSRegistration of the merger by absorption of CX
1st Sep 20165:34 pmRNSMerger by absorption of Catalunya Banc by BBVA
4th Aug 20168:42 amRNSSupplemental to the Offering Circular
1st Aug 20167:00 amRNSStress Test EBA
29th Jul 20167:09 amRNSInformation of Results 2Q2016
29th Jul 20167:02 amRNS2nd Quarter 2016 Results Presentation
29th Jul 20167:00 amRNS2nd Quarter Results Press Release
28th Jul 20166:03 pmRNSNEW AUDITOR SELECTION
28th Jul 20167:00 amRNSNew Organizational Structure
22nd Jul 20165:33 pmRNS2Q16 Results presentation announcement
24th Jun 20164:38 pmRNSPrice Monitoring Extension
23rd Jun 20167:00 amRNSDividend July 2016
9th May 20168:39 amRNSSupplemental to the Offering Circular
6th May 20169:59 amRNSBBVA Scrip Dividend
29th Apr 201612:45 pmRNS2015 Audited Financial Statements
28th Apr 20168:21 amRNSAmendment Results Presentation 1Q2016
28th Apr 20167:29 amRNSResults Presentation 1Q2016
28th Apr 20167:22 amRNSPress Release 1st Quarter Results 2016
28th Apr 20167:21 amRNS1st Quarter Results 2016
25th Apr 20165:02 pmRNSPresentation of results announcement 1Q2016
20th Apr 20167:00 amRNSOptional Dividend Result
8th Apr 20167:00 amRNSPreferred Securities
1st Apr 20167:00 amRNSModification about composition of committees
1st Apr 20167:00 amRNSOptional dividend
1st Apr 20167:00 amRNSIntegration process of BBVA Group
14th Mar 20167:00 amRNSIRS Pilar III Basilea
11th Mar 20162:52 pmRNSOptional dividend calendar
11th Mar 20162:51 pmRNSGeneral Meeting Agreements
11th Mar 20167:51 amRNSDBRS rating actions
24th Feb 20164:28 pmRNSHOME MEMBER STATE DISCLOSURE
10th Feb 20164:02 pmRNSSupplemental to the Offering Circular
10th Feb 201612:02 pmRNSBBVA's Annual Report 2015 (Spanish version)
10th Feb 201612:00 pmRNSBBVA's Annual Report 2015
8th Feb 20167:00 amRNSAnnual corporate governance report
5th Feb 20165:26 pmRNSIAR 2015
5th Feb 20168:38 amRNSAGENDA ANNUAL GENERAL MEETING OF SHAREHOLDERS
3rd Feb 20169:28 amRNSAnnual General Meeting 2016 Call
3rd Feb 20167:40 amRNS20160203 Folleto_eng
3rd Feb 20167:38 amRNS20160203 Results Presentation
3rd Feb 20167:17 amRNSPress Release 4Q15
29th Jan 20167:59 amRNS4Q15 Results presentation announcement
20th Jan 20168:30 amRNSPost-Stabilisation Notice - BBVA
14th Jan 201610:33 amRNSPublication of Final Terms
13th Jan 20168:06 amRNSReclassify several operating expenses
24th Dec 20157:00 amRNSBBVA SREP requirement
23rd Dec 20155:46 pmRNSEx-dividend date corrected January 2016

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.